The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
Shogo Kumagai(Chiba Cancer Center), Yosuke Togashi(Chiba Cancer Center), Takahiro Kamada(Chiba Cancer Center), Eri Sugiyama(Chiba Cancer Center), Hitomi Nishinakamura(Chiba Cancer Center), Yoshiko Takeuchi(Chiba Cancer Center), Vitaly Kochin(Nagoya University), Kota Itahashi(Chiba Cancer Center), Yuka Maeda(Chiba Cancer Center), Shigeyuki Matsui(Nagoya University), Takuma Shibahara(Hitachi (Japan)), Yasuho Yamashita(Hitachi (Japan)), Takuma Irie(Chiba Cancer Center), Ayaka Tsuge(Chiba Cancer Center), Shota Fukuoka(Chiba Cancer Center), Akihito Kawazoe(National Cancer Center Hospital East), Hibiki Udagawa(National Cancer Center Hospital East), Keisuke Kirita(National Cancer Center Hospital East), Keiju Aokage(National Cancer Center Hospital East), Genichiro Ishii(National Cancer Center Hospital East), Takeshi Kuwata(National Cancer Center Hospital East), Kenta Nakama, Masahito Kawazu, Toshihide Ueno, Naoya Yamazaki, Kōichi Goto(National Cancer Center Hospital East), Masahiro Tsuboi(National Cancer Center Hospital East), Hiroyuki Mano, Toshihiko Doi(National Cancer Center Hospital East), Kohei Shitara(National Cancer Center Hospital East), Hiroyoshi Nishikawa(Chiba Cancer Center)
Cited by 808
Abstract
Related Papers
No related papers found
Powered by citation graph analysis